Discover Research Beta
Browse peer-reviewed articles from Medwin Publishers' open access journals.
Showing 1–2 of 2 articles
"Koudouna A"
×
Outcomes of Lenalidomide Relapsed/Refractory Patients
Lenalidomide constitutes a key component of therapeutic strategies for multiple myeloma (MM), both in combination with dexamethasone and as maintenance treatment. However, patient…
Multiple Myeloma
Lenalidomide Refractoriness
iMiDs
Long-lasting Responses to Immunomodulatory Drugs (IMIDs) in Combination with Dexamethasone in Multiple Myeloma; Identification of Exceptional Responders at any Treatment Line
Background: There is a growing interest in the study of patients that achieve exceptionally long-lasting remissions although suffering from incurable neoplastic disorders. This is …
Multiple myeloma
Immunomodulatory drugs
Thalidomide